Citigroup Inc. trimmed its position in shares of Lazard, Inc. (NYSE:LAZ – Free Report) by 0.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 341,700 shares of the asset manager’s stock after selling 3,015 shares during the period. Citigroup Inc.’s holdings in Lazard were worth $17,215,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Interval Partners LP bought a new stake in Lazard during the 2nd quarter valued at $1,626,000. Swedbank AB acquired a new stake in Lazard in the first quarter worth about $6,733,000. Point72 Europe London LLP bought a new position in Lazard in the 2nd quarter valued at about $1,779,000. Arizona State Retirement System acquired a new position in Lazard during the 2nd quarter valued at about $934,000. Finally, Amica Mutual Insurance Co. bought a new stake in shares of Lazard during the 2nd quarter worth about $5,700,000. Institutional investors own 54.80% of the company’s stock.
Insider Transactions at Lazard
In other Lazard news, Chairman Kenneth M. Jacobs sold 87,770 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $48.08, for a total value of $4,219,981.60. Following the transaction, the chairman now owns 1,553,225 shares in the company, valued at $74,679,058. The trade was a 5.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 3.14% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Get Our Latest Analysis on Lazard
Lazard Stock Down 0.8 %
NYSE:LAZ opened at $57.71 on Thursday. Lazard, Inc. has a 1-year low of $28.60 and a 1-year high of $61.14. The firm has a market capitalization of $6.51 billion, a price-to-earnings ratio of 22.99 and a beta of 1.38. The company has a current ratio of 2.24, a quick ratio of 2.24 and a debt-to-equity ratio of 2.72. The business’s fifty day moving average price is $53.04 and its 200 day moving average price is $46.61.
Lazard (NYSE:LAZ – Get Free Report) last issued its earnings results on Thursday, October 31st. The asset manager reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.03). The business had revenue of $646.00 million during the quarter, compared to analyst estimates of $644.22 million. Lazard had a net margin of 8.28% and a return on equity of 42.20%. Lazard’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.10 EPS. On average, sell-side analysts forecast that Lazard, Inc. will post 2.27 earnings per share for the current fiscal year.
Lazard Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, November 8th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.47%. The ex-dividend date of this dividend was Friday, November 8th. Lazard’s dividend payout ratio is currently 79.68%.
Lazard Profile
Lazard, Inc, together with its subsidiaries, operates as a financial advisory and asset management firm in North and South America, Europe, the Middle East, Asia, and Australia. It operates in two segments, Financial Advisory and Asset Management. The Financial Advisory segment offers financial advisory services, such as mergers and acquisitions, capital markets, shareholder, sovereign, geopolitical advisory, and other strategic advisory services, as well as restructuring and liability management, and capital raising and placement services.
Recommended Stories
- Five stocks we like better than Lazard
- What is a Stock Market Index and How Do You Use Them?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Using the MarketBeat Dividend Yield Calculator
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is MarketRankā¢? How to Use it
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding LAZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lazard, Inc. (NYSE:LAZ – Free Report).
Receive News & Ratings for Lazard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lazard and related companies with MarketBeat.com's FREE daily email newsletter.